Obesity drugmaker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
ASTRAZENECA’S market value surged above £200 billion (S$338 billion) for the first time after a big bet on cancer drugs ...
Citi estimates Zantac settlement costs at US$3 billionGSK shares plunged in the wake of a court ruling that the UK ...
Japan’s Asahi Kasei said on Tuesday (May 28) it offered to acquire Calliditas Therapeutics for about US$1.1 billion as part ...
ELI Lilly kicked off construction of a new plant to boost the production of its wildly popular weight-loss drugs, which ...
A CHINESE drugmaker has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for its approval. Hangzhou ...
A DRUGMAKER in China has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for approval ...
A JAPANESE drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more ...
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more ...
International Business Weekly is an American entertainment magazine. We cover business News & feature exclusive interviews with many notable figures
Copyright © 2024 - International Business Weekly